We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tenet Healthcare (THC) Stock Slides as Market Rises: Facts to Know Before You Trade
Read MoreHide Full Article
In the latest trading session, Tenet Healthcare (THC - Free Report) closed at $192.99, marking a -1.15% move from the previous day. The stock's performance was behind the S&P 500's daily gain of 1.02%. At the same time, the Dow added 0.63%, and the tech-heavy Nasdaq gained 1.23%.
The hospital operator's stock has dropped by 14.23% in the past month, falling short of the Medical sector's loss of 4.81% and the S&P 500's gain of 0.63%.
The investment community will be closely monitoring the performance of Tenet Healthcare in its forthcoming earnings report. The company is scheduled to release its earnings on April 30, 2026. In that report, analysts expect Tenet Healthcare to post earnings of $4.19 per share. This would mark a year-over-year decline of 3.9%. Our most recent consensus estimate is calling for quarterly revenue of $5.39 billion, up 3.15% from the year-ago period.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $17.3 per share and revenue of $22.01 billion, indicating changes of +3.1% and +3.27%, respectively, compared to the previous year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Tenet Healthcare. These latest adjustments often mirror the shifting dynamics of short-term business patterns. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Currently, Tenet Healthcare is carrying a Zacks Rank of #3 (Hold).
Digging into valuation, Tenet Healthcare currently has a Forward P/E ratio of 11.29. This denotes no noticeable deviation relative to the industry average Forward P/E of 11.29.
It is also worth noting that THC currently has a PEG ratio of 0.94. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. Medical - Hospital stocks are, on average, holding a PEG ratio of 0.94 based on yesterday's closing prices.
The Medical - Hospital industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 56, positioning it in the top 23% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Tenet Healthcare (THC) Stock Slides as Market Rises: Facts to Know Before You Trade
In the latest trading session, Tenet Healthcare (THC - Free Report) closed at $192.99, marking a -1.15% move from the previous day. The stock's performance was behind the S&P 500's daily gain of 1.02%. At the same time, the Dow added 0.63%, and the tech-heavy Nasdaq gained 1.23%.
The hospital operator's stock has dropped by 14.23% in the past month, falling short of the Medical sector's loss of 4.81% and the S&P 500's gain of 0.63%.
The investment community will be closely monitoring the performance of Tenet Healthcare in its forthcoming earnings report. The company is scheduled to release its earnings on April 30, 2026. In that report, analysts expect Tenet Healthcare to post earnings of $4.19 per share. This would mark a year-over-year decline of 3.9%. Our most recent consensus estimate is calling for quarterly revenue of $5.39 billion, up 3.15% from the year-ago period.
Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $17.3 per share and revenue of $22.01 billion, indicating changes of +3.1% and +3.27%, respectively, compared to the previous year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Tenet Healthcare. These latest adjustments often mirror the shifting dynamics of short-term business patterns. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Currently, Tenet Healthcare is carrying a Zacks Rank of #3 (Hold).
Digging into valuation, Tenet Healthcare currently has a Forward P/E ratio of 11.29. This denotes no noticeable deviation relative to the industry average Forward P/E of 11.29.
It is also worth noting that THC currently has a PEG ratio of 0.94. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. Medical - Hospital stocks are, on average, holding a PEG ratio of 0.94 based on yesterday's closing prices.
The Medical - Hospital industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 56, positioning it in the top 23% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.